Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to CU20100092ApriorityCriticalpatent/CU20100092A7/en
Publication of CU20100092A7publicationCriticalpatent/CU20100092A7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
En la presente se dan a conocer ácidos alfa-amino-borónicos y sus derivados, los cuales actúan como inhibidores de beta-lactamasas. También, en la presente se dan a conocer composiciones farmacéuticas que comprenden ácidos alfa-amino-borónicos, y métodos de uso de las mismas.Alpha-amino-boronic acids and their derivatives, which act as beta-lactamase inhibitors, are disclosed herein. Also, pharmaceutical compositions comprising alpha-amino-boronic acids, and methods of use thereof, are disclosed herein.
NEW DERIVATIVES OF 6-TRIALZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS.